Sloan Program grows with new collaboration, new executives-in-residence

Sloan Program in Health Administration students will be working with five executives-in-residence. Sloan Program Associate Director Julie Carmalt says the students will have a range of mentoring and networking opportunities while learning from prominent leaders in the health care field.

Around Cornell

Consumers embrace milk carton QR codes, may cut food waste

Milk carton “use-by” dates soon may be a quaint relic. A new Cornell study finds that consumers like QR codes, better depicting how long milk is drinkable – creating less food waste.

New cancer subtype may illuminate treatment strategy

Researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have identified a previously unrecognized form of hormone therapy-resistant prostate cancer, as well as a set of molecules that drive its growth.

Higher dengue rates found near public transit in low-income areas

In Medellin, Colombia, low-income residents who lived in close proximity to new public transit stations had increased rates of mosquito-transmitted dengue fever, according to a new study.

How to get people to follow the rules: lessons from the pandemic’s ‘great experiment’

When a deadly global pandemic broke out, compliance — the act of following rules — became critical. Yet many people didn’t adhere to the rules. Professor John, from the Cornell Law School, explains how getting people to work together and follow rules takes careful thought and planning, and that compliance inside businesses and organizations is essential to accomplishing just about anything.  

Around Cornell

First class of Milstein students heads toward graduation

Twenty seniors in the Milstein Program in Technology & Humanity will graduate this year with degrees in everything from biology to linguistics to computer science to physics.

Around Cornell

Study reveals potential therapies for aggressive lymphoma

The Weill Cornell Medicine research takes a step toward precision medicine for a type of cancer that disproportionately affects people with African ancestry, an underserved population. 

Artificial cilia could someday power diagnostic devices

Cornell researchers designed a micro-sized artificial cilial system that could eventually enable low-cost, portable diagnostic devices for testing blood samples, manipulating cells or assisting in microfabrication processes.

Startup Roundup: Antithesis Foods, Guard Medical, C2i, Bactana

Cornell startup Antithesis Foods and Bactana were awarded NSF small-business grants, as Guard Medical raises $11 million in Series B investments and C2i launches a disease test in Europe.